Navigation Links
Fate Therapeutics Initiates Phase 2 Clinical Study of ProHema for the Treatment of Hematologic Malignancies
Date:11/27/2012

cord blood transplant (dUCBT), the median time to neutrophil recovery (> 500 cells/microliter) with ProHema was 17.5 days, which compares favorably to historical norms for patients undergoing dUCBT.  In that study, ProHema provided the dominant source of hematopoiesis in 10 of 12 evaluable subjects, suggesting that treatment with ProHema may accelerate engraftment and drive durable and preferential reconstitution.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators.  The Company's first clinical program, ProHema, is an innovative cord blood-derived cell therapy containing ex vivo pharmacologically-modulated hematopoietic stem cells and is being developed to improve hematopoietic reconstitution in patients undergoing stem cell transplant.  In addition, Fate Therapeutics has preclinical programs of novel in vivo stem cell modulators for skeletal muscle regeneration and hearing restoration.  To advance its discovery and development efforts, the Company applies its award-winning, proprietary, induced pluripotent stem cell technology to generate rare cell populations and model disease.  Fate Therapeutics is headquartered in San Diego, CA, with a subsidiary in Ottawa, Canada.  For more information, please visit www.fatetherapeutics.com.


'/>"/>
SOURCE Fate Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Epizyme Publishes Current Review on Targeting Protein Methyltransferases for Personalized Cancer Therapeutics
2. MabVax Therapeutics Closes $5.25 Million Financing with Numoda Capital Innovations, Burrill Capital Fund IV, and RTP Venture Fund
3. Cystic Fibrosis Foundation Therapeutics Announces $58 Million CF Drug Discovery Agreement with Pfizer
4. Echo Therapeutics Hires Daniel Sunday as Vice President of Manufacturing and Global Supply Chain
5. Caliber and ImmunGene Launch Valor Biotherapeutics, a Joint Venture to Develop Antibody-Interferon Fusion Therapeutics to Treat Cancers
6. Echo Therapeutics Chosen to Present at the 12th Annual Diabetes Technology Meeting
7. Immunomic Therapeutics Begins Phase I Japanese Red Cedar JRC-LAMP-Vax Vaccine Safety Study
8. Stemline Therapeutics Lead Clinical Candidate SL-401 Induces a Complete Response in a Patient with a Drug-Refractory Plasmacytoid Dendritic Cell Neoplasm
9. Echo Therapeutics Announces Third Quarter 2012 Financial Results
10. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
11. Particle Sciences Develops Novel Ocular Formulation for Eyeon Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 The Competitive Intelligence (CI) function is ... CI leaders who adjust will succeed, and those who ... Best Practices, LLC study CI leaders from 32 biopharmaceutical ... - Use secondary research whenever possible - it,s ... - Internal staff who are creative thinkers provide the ...
(Date:8/29/2014)... -- Pomerantz LLP has filed a class action lawsuit ... EDAP ) and certain of its officers.  The ... District of New York , and ... consisting of all persons or entities who purchased EDAP ... inclusive (the "Class Period"). This class action seeks to recover ...
(Date:8/29/2014)...   Mast Therapeutics, Inc. (NYSE MKT: ... Santosh Vetticaden, Chief Medical Officer and Senior Vice ... reasons, in mid-September.  Edwin L. Parsley , ... which Mast acquired earlier this year, will assume ... Chief Medical Officer.  Dr. Parsley previously was with ...
Breaking Medicine Technology:Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4
... announced the initiation of a landmark Phase 2 ... developed to improve neurological function in patients with ... In accordance with its internal focus on scientific ... at a peer-attended symposium at the American Spinal ...
... April 23, 2012 Medela convened the 7th ... on April 20-21, 2012. The annual event, attended ... lactation consultants, highlighted the latest insights into breastfeeding ... supporting breastfeeding women and their families through research ...
Cached Medicine Technology:Asubio Initiates Landmark Clinical Study in Spinal Cord Injury 2Asubio Initiates Landmark Clinical Study in Spinal Cord Injury 3Latest Findings in Breastfeeding Science Presented at Medela's 7th International Breastfeeding and Lactation Symposium 2Latest Findings in Breastfeeding Science Presented at Medela's 7th International Breastfeeding and Lactation Symposium 3
(Date:8/29/2014)... A recent article discusses the creation ... clothing store for men with gynecomastia, or male breasts, to ... their problem. Board-certified plastic surgeon Dr. Chasan is familiar with ... people only associate male breasts with men who are excessively ... of all ages, often starting in adolescence. Men with the ...
(Date:8/29/2014)... Pursuing its deepest desires to help ... a stunning new design that promises to redefine the ... notable surrogacy platform has witnessed a 42 percent increase ... a month, the FindSurrogateMother.com community is formed by hopeful ... goal — the precious gift of life. , Whether ...
(Date:8/29/2014)... report released yesterday by the Mental Health Commission ... health training and education that police personnel receive. ... issue for Canada,s police community, and today,s report ... enforcement and people with mental illnesses," says Queen,s ... an interest in the area of police psychology. ...
(Date:8/29/2014)... D.C. (PRWEB) August 29, 2014 Today, ... Community Anti-Drug Coalitions of America (CADCA) , the nation’s ... in response to President Obama’s intent to nominate Michael ... , “CADCA strongly supports President Obama’s decision to nominate ... is the ideal person to hold this important position ...
(Date:8/29/2014)... August 29, 2014 Thirteen Novant ... prestigious Great 100 Nurses in North Carolina ... nursing excellence and provides scholarships to nursing students at ... from Novant Health Presbyterian Medical Center are: ... Kelley, Nora King, Lissa Ready, Amber Segerlin, Carmen Smith, ...
Breaking Medicine News(10 mins):Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 2Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 3Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 3Health News:Report advocates improved police training 2Health News:CADCA Statement on Nomination of Michael Botticelli as U.S. Drug Czar 2Health News:Great 100 Honors 13 Novant Health Nurses 2
... Prevention efforts ,have run out of steam, expert says, , , ... risk of dying prematurely? Don,t smoke and keep a healthy ... about one in five deaths among U.S. adults, according to ... to be linked with premature death, the magnitude of the ...
... East and the Asia-Pacific region , , TUESDAY, April 28 (HealthDay ... in the United States has doubled to 40, U.S. health ... a New York City high school that had previously reported ... Tuesday were listing the number of U.S. cases at 50, ...
... Trends Suggest These Agents Will Face Greater Use of ... on Commercial Health Plans, According to a New Report ... N.J., April 28 HealthLeaders-InterStudy and Fingertip ... antihypertensives are expected to face tougher formulary restrictions. According ...
... Doors with Offices in New York ... 28 Diversified Agency Services (DAS) today announced the launch ... New York and London. TogoRun specializes in healthcare, pharmaceutical ... roster includes many of the world,s leading healthcare brands.The new ...
... by Troops Coming Home from WarCAMBRIDGE, Mass., April 28 ... Veterans Affairs Appropriations Subcommittee on behalf of ALS patients, ... (ALS TDI), last Thursday. Dr. Appel urged congress ... such as the one at ALS TDI. Dr. ...
... 28 Verathon(R) is pleased to announce the new ... with Urologists in mind, the BVM 9500 measures both ... noninvasively to help diagnose bladder dysfunction, including BPH (benign ... new addition to the BladderScan(R) BVI 9000 series made ...
Cached Medicine News:Health News:1 in 5 U.S. Deaths Attributed to Smoking, High BP 2Health News:Some Reports Put Number of U.S. Swine Flu Cases at 50 2Health News:Some Reports Put Number of U.S. Swine Flu Cases at 50 3Health News:Some Reports Put Number of U.S. Swine Flu Cases at 50 4Health News:Some Reports Put Number of U.S. Swine Flu Cases at 50 5Health News:Fixed Dosed Combination Agents and Novel Antihypertensives Are Expected to Face Tougher Formulary Restrictions 2Health News:Fixed Dosed Combination Agents and Novel Antihypertensives Are Expected to Face Tougher Formulary Restrictions 3Health News:Diversified Agency Services Network Launches TogoRun(TM), A New Global Healthcare Communications Agency 2Health News:Diversified Agency Services Network Launches TogoRun(TM), A New Global Healthcare Communications Agency 3Health News:Diversified Agency Services Network Launches TogoRun(TM), A New Global Healthcare Communications Agency 4Health News:ALS Therapy Development Institute Delivers Impassioned Testimony to Congressional Subcommittee on Veterans Affairs 2Health News:ALS Therapy Development Institute Delivers Impassioned Testimony to Congressional Subcommittee on Veterans Affairs 3Health News:Verathon(R) Introduces BladderScan(R) BVM 9500 Bladder Volume Instrument To Help Urologists Diagnose Bladder Dysfunction 2Health News:Verathon(R) Introduces BladderScan(R) BVM 9500 Bladder Volume Instrument To Help Urologists Diagnose Bladder Dysfunction 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: